BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 10660629)

  • 81. A new model of cell cycle-regulated transcription: repression of the cyclin A promoter by CDF-1 and anti-repression by E2F.
    Liu N; Lucibello FC; Engeland K; Müller R
    Oncogene; 1998 Jun; 16(23):2957-63. PubMed ID: 9662327
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activity.
    Turley JM; Ruscetti FW; Kim SJ; Fu T; Gou FV; Birchenall-Roberts MC
    Cancer Res; 1997 Jul; 57(13):2668-75. PubMed ID: 9205075
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A mathematical model of the regulation of the G1 phase of Rb+/+ and Rb-/- mouse embryonic fibroblasts and an osteosarcoma cell line.
    Obeyesekere MN; Knudsen ES; Wang JY; Zimmerman SO
    Cell Prolif; 1997; 30(3-4):171-94. PubMed ID: 9375029
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Incomplete penetrance of familial retinoblastoma linked to germ-line mutations that result in partial loss of RB function.
    Otterson GA; Chen Wd; Coxon AB; Khleif SN; Kaye FJ
    Proc Natl Acad Sci U S A; 1997 Oct; 94(22):12036-40. PubMed ID: 9342358
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Mechanism of active transcriptional repression by the retinoblastoma protein.
    Weintraub SJ; Chow KN; Luo RX; Zhang SH; He S; Dean DC
    Nature; 1995 Jun; 375(6534):812-5. PubMed ID: 7596417
    [TBL] [Abstract][Full Text] [Related]  

  • 86. E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo.
    Wang D; Russell JL; Johnson DG
    Mol Cell Biol; 2000 May; 20(10):3417-24. PubMed ID: 10779331
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit.
    Hofmann F; Livingston DM
    Genes Dev; 1996 Apr; 10(7):851-61. PubMed ID: 8846921
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Cytosine methylation transforms an E2F site in the retinoblastoma gene promoter into a binding site for the general repressor methylcytosine-binding protein 2 (MeCP2).
    Di Fiore B; Palena A; Felsani A; Palitti F; Caruso M; Lavia P
    Nucleic Acids Res; 1999 Jul; 27(14):2852-9. PubMed ID: 10390525
    [TBL] [Abstract][Full Text] [Related]  

  • 89. E2F-1 and a cyclin-like DNA repair enzyme, uracil-DNA glycosylase, provide evidence for an autoregulatory mechanism for transcription.
    Walsh MJ; Shue G; Spidoni K; Kapoor A
    J Biol Chem; 1995 Mar; 270(10):5289-98. PubMed ID: 7534293
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Cdk2-dependent and -independent pathways in E2F-mediated S phase induction.
    Arata Y; Fujita M; Ohtani K; Kijima S; Kato JY
    J Biol Chem; 2000 Mar; 275(9):6337-45. PubMed ID: 10692433
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice.
    Yamasaki L; Bronson R; Williams BO; Dyson NJ; Harlow E; Jacks T
    Nat Genet; 1998 Apr; 18(4):360-4. PubMed ID: 9537419
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest.
    Puga A; Barnes SJ; Dalton TP; Chang Cy; Knudsen ES; Maier MA
    J Biol Chem; 2000 Jan; 275(4):2943-50. PubMed ID: 10644764
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A role for nuclear phospholipase Cbeta 1 in cell cycle control.
    Faenza I; Matteucci A; Manzoli L; Billi AM; Aluigi M; Peruzzi D; Vitale M; Castorina S; Suh PG; Cocco L
    J Biol Chem; 2000 Sep; 275(39):30520-4. PubMed ID: 10913438
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Rac and Cdc42 are potent stimulators of E2F-dependent transcription capable of promoting retinoblastoma susceptibility gene product hyperphosphorylation.
    Gjoerup O; Lukas J; Bartek J; Willumsen BM
    J Biol Chem; 1998 Jul; 273(30):18812-8. PubMed ID: 9668055
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Distinct cellular factors regulate the c-myb promoter through its E2F element.
    Campanero MR; Armstrong M; Flemington E
    Mol Cell Biol; 1999 Dec; 19(12):8442-50. PubMed ID: 10567569
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression.
    Takahashi Y; Rayman JB; Dynlacht BD
    Genes Dev; 2000 Apr; 14(7):804-16. PubMed ID: 10766737
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The transcription factor E2F-1 is a downstream target of RB action.
    Qin XQ; Livingston DM; Ewen M; Sellers WR; Arany Z; Kaelin WG
    Mol Cell Biol; 1995 Feb; 15(2):742-55. PubMed ID: 7823942
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Human herpesvirus 6 (HHV-6) alters E2F1/Rb pathways and utilizes the E2F1 transcription factor to express viral genes.
    Sharon E; Volchek L; Frenkel N
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):451-6. PubMed ID: 24335704
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Human SWI-SNF component BRG1 represses transcription of the c-fos gene.
    Murphy DJ; Hardy S; Engel DA
    Mol Cell Biol; 1999 Apr; 19(4):2724-33. PubMed ID: 10082538
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Regulation of the human cyclin-dependent kinase inhibitor p18INK4c by the transcription factors E2F1 and Sp1.
    Blais A; Monté D; Pouliot F; Labrie C
    J Biol Chem; 2002 Aug; 277(35):31679-93. PubMed ID: 12077144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.